Article Information
PubMed
Print ISSN
Online ISSN
History
- Received January 13, 2006
- Accepted March 29, 2006
- Published online July 13, 2006.
Article Versions
- Earlier version (May 11, 2006 - 08:22).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Brianne Weiss,
- Andrew Alt,
- Ann Marie Ogden,
- Mary Gates,
- Donna K. Dieckman,
- Amy Clemens-Smith,
- Ken H. Ho,
- Keith Jarvie,
- Geihan Rizkalla,
- Rebecca A. Wright,
- David O. Calligaro,
- Darryle Schoepp,
- Edward L. Mattiuz,
- Robert E. Stratford,
- Bryan Johnson,
- Craig Salhoff,
- Mary Katofiasc,
- Lee A. Phebus,
- Kathryn Schenck,
- Marlene Cohen,
- Sandra A. Filla,
- Paul L. Ornstein,
- Kirk W. Johnson and
- David Bleakman
- Eli Lilly and Company, Neuroscience Research, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana (B.W., A.A., A.M.O., M.G., D.K.D., A.C.-S., K.H.H., R.A.W., D.O.C., D.S., E.L.M., R.E.S., B.J., C.S., M.K., L.A.P., K.S., M.C., S.A.F., P.L.O., K.W.J., D.B.); and Allelix Biopharmaceuticals, Mississauga, Ontario, Canada (K.H.H., K.J., G.R.)
- Address correspondence to:
Dr. David Bleakman, Neuroscience Discovery Research, Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly and Company, Indianapolis, IN 46285-0510. E-mail: bleakman_david{at}lilly.com